Navigation Links
Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
Date:5/23/2013

SOUTH EASTON, Mass., May 23, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2013 financial results and to provide a business update. The teleconference information is provided below:

Date: Thursday, May 23, 2013
Time: 11:00 a.m. Eastern Daylight Time (EDT)

Dial-in: (800) 875-3456 (U.S.); (800) 648-0973 (Canada); (302) 607-2001 (Int'l)
Passcode: VS22823

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call and will be accessible through the Company's website.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications.

For more information about PBI and this press release, please click on the following link:
http://www.pressurebiosciences.com




Investor Contacts:

Richard T. Schumacher, President & CEO

Pressure BioSciences, Inc.

Conrad Mir, CFO

(T) 508-230-1828


'/>"/>
SOURCE Pressure BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. High pressure gold nanocrystal structure revealed
2. Further Advancements Made in the Development of an Improved Method For Rape Kit Testing Using Pressure BioSciences Patented Pressure Cycling Technology (PCT)
3. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
4. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
5. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
6. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
7. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
8. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
9. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
10. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
11. The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... ANGELES, CA (PRWEB) , ... May 19, 2017 ... ... the annual meeting and educational conference of the American Association of Bioanalysts (AAB) ... the Galleria Hotel in Houston. The conference reinforces AAB’s commitment to excellence in ...
(Date:5/19/2017)... Philadelphia, PA (PRWEB) , ... May 19, 2017 ... ... for its QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, ... Pennsylvania, New Jersey and Delaware, are encouraged to submit proposals. QED, now in ...
(Date:5/18/2017)... , ... May 16, 2017 , ... Clinical Supplies Management ... appointments as the company continues to grow. CSM has doubled in size over ... is executing an aggressive growth strategy. , Roger Gasper joins CSM as Chief Financial ...
(Date:5/18/2017)... Massachusetts (PRWEB) , ... May 17, 2017 , ... ... company specializing in medical device compliance and commercialization, has just released version 9.0 ... of work into this latest version of Cockpit,” says David Cronin, CEO of ...
Breaking Biology Technology:
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
Breaking Biology News(10 mins):